Navigation Links
United BioSource Scientist Leads Development of New Guidelines for Drug Reimbursement by German Government
Date:2/19/2008

New Methods Delivered to German Government in January

BETHESDA, Md., Feb. 19 /PRNewswire/ -- United BioSource Corporation's (UBC) director of global health economics has just delivered to the German government one of the most significant revisions of drug policy produced in Europe in more than a decade.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )

The 70-page report, commissioned last year by Germany's Institute for Quality and Efficiency In Healthcare (IQWiG), will be used by the German government to evaluate drugs and devices and to set prices and reimbursement levels for those products. The document is expected to be widely influential both inside and outside of Germany, the third largest pharmaceutical market in the world.

The director and main author of the report, Jaime Caro, MD, Senior Vice President of UBC, was selected by the German government to head the eight- member international panel because of his recognized authority in the design and implementation of cutting-edge modeling and analytic techniques for health technology assessments, particularly in determining the value and safety of medical products.

According to Dr. Caro, "It was an immense honor to lead such a distinguished panel in developing pioneering methods for economic evaluation. These methods will have a strong influence on the efforts of society to control health care costs. I am very glad that with my team of experienced professionals at UBC, we can work towards improving health outcomes."

Made public in Berlin on January 24, 2008 by IQWiG, the findings and recommendations of the expert panel, if accepted, will directly impact the pricing and reimbursement of pharmaceuticals, biologicals and medical devices in Germany, which has the largest population of any EU nation.

Dr. Caro recommends that companies with marketed products and products in development set up a process to assess where the pharmaceuticals fall under the new methods and "be prepared to defend their position, understanding that they might need additional data or other strategies."

The report is titled Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System.

United BioSource Corporation (UBC) is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in offering new and innovative ways to study drugs and devices by offering expertise in science, strategy and execution.

UBC is headquartered in Bethesda, Maryland, with offices in the United States, Canada, Western Europe (including Cologne, Germany), Eastern Europe and South America. For more information, visit http://www.unitedbiosource.com or call 866-458-1096.

CONTACT: Tess Drahzal, +1 (240) 644-0420, info@unitedbiosource.com
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Jaime Caro, MD http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=73597


'/>"/>
SOURCE United BioSource Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States
2. Davis Vision, United Concordia Free Clinic Promotes Childrens Eye and Dental Health
3. United Concordia Celebrates National Childrens Dental Health Month
4. UnitedHealthcare of the River Valley Acts to Help Tennessee Victims of Storm Devastation
5. Access Is Not Enough: What It Will Take to Transform Health Care in the United States
6. United Concordia Unveils New Online Capabilities for Producers
7. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
8. MedWaves, Inc. Announces Receipt of United States Food and Drug Administration 510k Clearance to Market Its Patented Microwave Coagulation/Ablation System
9. Peninsula United Methodist Homes Completes Enterprise-Wide Deployment of AccuNurse Voice-Assisted Care
10. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
11. United States Joins False Claims Act Cases Against Three New Jersey Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... , ... May 05, 2016 , ... Einstein Medical ... Twitter feed to cover the latest news and commentary at the 2016 ASCRS/ASOA Symposium ... meeting of the American Society of Cataract and Refractive Surgery and the American Society ...
(Date:5/5/2016)... ... May 05, 2016 , ... TLC Laser Eye Centers ... California. The laser eye center will now be called “Gordon Schanzlin New Vision Institute, ... will remain at the full-service facility to ensure that patients continue to receive the ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... successful results with IVF and with egg freezing, today announced the grand opening ... and highest quality fertility care, Spring Fertility offers both fertility preservation (egg, sperm, ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Seminars for Business Journalists , led by the Wharton School’s most prominent ... issues.  This one-day program at the Wharton School’s San Francisco campus will ...
(Date:5/5/2016)... Indianapolis, IN (PRWEB) , ... May 05, 2016 ... ... employee benefits advisory organization, announces McLaughlin & Smoak Benefits as the latest addition ... & Smoak Benefits has a dedicated team of compliance, wellness, human resources, and ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016  While you may be familiar with watching a film or ... also known as ultra-high-definition or 8MP in the Medical Industry.  Ampronix  is a renowned authorized ... innovative technology. Photo - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
(Date:5/3/2016)... Inc. (NYSE: DPLO) announced today that it is celebrating Hepatitis Awareness Month with a campaign ... their personal story and encourage those at risk to get tested and begin the road ... ... ... Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... 3, 2016 According to market ... Development, Growth and Demand Forecast to 2022 - Industry ... (High Field, Very High Field, Low to Mid Field, ... Neck, Spine, Musculoskeletal, Vascular, Breast, Pelvic and Abdomen, Cardiac, ... imaging (MRI) market was valued at $5,351.7 million in ...
Breaking Medicine Technology: